Scope of engagement
UX Elevation Capital (operating as TrustChain) provides two primary services: (a) operational verification mandates delivering a Sovereign Readiness Score and Clinical Verdict on cross-border investment targets; and (b) capital introduction services connecting operationally verified founders with institutional investors in the GCC and Asia corridor.
Each engagement is governed by a separate signed scope agreement executed between UX Elevation Capital and the client prior to commencement of work. The scope agreement takes precedence over these general terms in the event of any conflict.
Fee structure
Verification mandates are fixed-fee engagements. The fee is specified in the scope agreement and is payable on execution of that agreement. No refunds are issued once verification has commenced. If UX Elevation Capital determines that the mandate cannot be completed due to access refusal or force majeure, a partial refund proportional to work completed may be offered at UX Elevation Capital's discretion.
Capital Introduction engagements require an upfront retainer of $4,500 (non-refundable) covering material preparation and the first four investor introductions. A success fee of 6-8% of total capital raised through the network is payable on close of any investment that originated from a TrustChain introduction. The applicable success fee percentage is specified in the scope agreement.
Partner programme payments — Referral Partners at 15% and Distribution Partners at 20% — are governed by separate partnership agreements and are payable within 7 business days of mandate fee receipt for confirmed closed engagements originating from the partner's referral.
All fees are stated in USD. Late payment may result in suspension of services and accrual of interest at 1.5% per month on outstanding balances.
Nature and limitations of verdicts
A TrustChain Clinical Verdict reflects operational reality at the specific point in time at which verification was conducted. It does not constitute investment advice, does not guarantee future business performance, and does not warrant that the verified business will remain in the same operational condition after the verification date.
A GO verdict confirms that the operational claims reviewed were consistent with physical reality at the time of verification. It does not eliminate market risk, execution risk, or the risk that conditions change between verification and capital deployment.
UX Elevation Capital accepts no liability for investment losses arising from reliance on a TrustChain verdict. The verification mandate is a risk reduction instrument. It is not a guarantee of investment outcome, and reliance on it does not transfer any legal or fiduciary duty to UX Elevation Capital.
Mutual confidentiality obligations
Both parties agree to maintain strict confidentiality over all non-public information shared during an engagement. This obligation survives termination of the engagement.
UX Elevation Capital will not disclose client identity, target company identity, deal details, mandate scope, or verdict outcomes to any third party without prior written consent from the client. Case studies may be published in anonymised form only, with no identifying information about the client, target, geography, or deal value.
Clients agree to maintain confidentiality over the 44-marker protocol methodology, the Sovereign Readiness Score framework, pricing structures, and internal processes of UX Elevation Capital. These constitute proprietary intellectual property of UX Elevation Capital.
Ownership of methodology and reports
The 44-marker verification protocol, Sovereign Readiness Score framework, and Clinical Verdict Report format are the intellectual property of UX Elevation Capital. Delivery of a report to a client does not transfer ownership of the underlying methodology.
Clients are granted a non-exclusive, non-transferable licence to use the Clinical Verdict Report and evidence package for the internal investment decision-making purposes specified in the scope agreement. Redistribution, publication, or commercial use of any report without written authorisation is prohibited.
Liability cap and exclusions
To the maximum extent permitted by applicable law, UX Elevation Capital's total aggregate liability to any client in connection with any engagement shall not exceed the total fees paid by that client for the specific engagement giving rise to the claim.
UX Elevation Capital shall not be liable for any indirect, consequential, incidental, special, or punitive damages, including but not limited to loss of profits, loss of investment, or opportunity costs, even if advised of the possibility of such damages.
Jurisdiction and dispute resolution
These terms are governed by the laws of the State of Delaware, United States. UX Elevation Capital is incorporated in Delaware. Any dispute arising under or in connection with these terms that cannot be resolved by good-faith negotiation between the parties shall be subject to binding arbitration administered by the American Arbitration Association in Wilmington, Delaware, unless otherwise agreed in writing in the scope agreement.
For questions regarding these terms, contact ahmed@uxelevation.com or call +1 818-858-7905.